Compare TG Therapeutics Inc (TGTX) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? TG Therapeutics Inc trades at $55.37 (market cap $8.16B), while ZIM Integrated Shipping Services Ltd trades at $29.99 (market cap $3.65B). The key difference: TG Therapeutics Inc is far larger — about 2.2× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TG Therapeutics Inc for 16 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| TGTX | ZIM | |
|---|---|---|
Market Cap | $8.16B | $3.65B |
Volume | 1,735,121 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $59.06 | $30.51 |
52-Week Low | $26.94 | $12.44 |
Typical Hold Time | 16 Days | 27 Days |
Enterprise Value | $8.37B | $7.32B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TG Therapeutics (TGTX) trades at $55.37, up 4.57% today, but faces a bearish technical signal with recent earnings misses. Strong revenue growth is driven by BRIUMVI, with 2026 guidance raised to $950 million, though profitability is pressured by investments. A shareholder investigation and volatile cash flows add uncertainty, while analyst consensus remains bullish with an $80.50 price target.
The outlook hinges on BRIUMVI's market share gains and subcutaneous formulation progress, offering upside if execution succeeds. Risks include the fiduciary investigation, competitive pressures, and reliance on a single product. The stock presents a high-risk, high-reward opportunity, with current valuation reflecting growth expectations but vulnerable to setbacks.
ZIM trades at $29.99, near its 52-week high of $30.96, reflecting strong momentum. The stock shows a bullish technical trend with moving averages supporting upside, while oscillators are neutral. Fundamentally, Q2 2026 earnings beat expectations with EPS of $0.53 versus a forecasted loss, driven by higher freight rates and volumes. Revenue for 2026 is projected at $6.4B with a net income margin of 2.15%. The company faces a pivotal moment with Hapag-Lloyd's acquisition offer under Israeli government review.
The outlook is mixed: operational improvements and record transpacific rates offer upside, but merger uncertainty caps near-term gains. Risks include deal rejection, competitive pressures, and volatile shipping rates. Analysts are cautious, with 67% hold ratings, signaling wait-and-see sentiment amid the acquisition saga.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
